41
Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms
Condition(s):Infantile SpasmLast Updated:November 18, 2019Unknown status
Methylprednisolone as an Intervention: 1962 Clinical Trials, Page 5 of 197
Hide Studies Not Open or Pending
42
Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)
Condition(s):Acute Exacerbation of Remitting Relapsing Multiple Sclerosis; Clinically Isolated SyndromeLast Updated:October 6, 2016Terminated
43
Platelet-rich Plasma (PRP) Injection for Treating Shoulder Subacromial Impingement Syndrome
Condition(s):Shoulder Impingement SyndromeLast Updated:June 28, 2017Terminated
44
High-dose Methylprednisolone and Rituximab in High Risk B-CLL
Condition(s):Chronic B-Lymphocytic LeukemiaLast Updated:February 23, 2010Completed
45
Effect of Prednisolone Treatment on Uterine Natural Killer Cells
Condition(s):Recurrent MiscarriageLast Updated:November 1, 2022Recruiting
46
Evaluation of the Bioavailability of Methylprednisolone
Condition(s):Methylprednisone Administration; Intranasal Administration; Intravenous Administration; Healthy SubjectsLast Updated:December 16, 2022Completed
47
Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer
Condition(s):Non-small Cell Lung CancerLast Updated:November 30, 2022Terminated
48
Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients
Condition(s):Covid19Last Updated:May 23, 2022Completed
49
Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19
Condition(s):Cytokine Release Syndrome; Covid-19Last Updated:March 29, 2022Terminated
50
Systemic Methylprednisolone in Chronic Rhinosinusitis
Condition(s):Chronic Rhinosinusitis; ChildrenLast Updated:September 21, 2010Completed